YU44411B - Process for obtaining a monoclonal antibody - Google Patents

Process for obtaining a monoclonal antibody

Info

Publication number
YU44411B
YU44411B YU2392/80A YU239280A YU44411B YU 44411 B YU44411 B YU 44411B YU 2392/80 A YU2392/80 A YU 2392/80A YU 239280 A YU239280 A YU 239280A YU 44411 B YU44411 B YU 44411B
Authority
YU
Yugoslavia
Prior art keywords
obtaining
monoclonal antibody
monoclonal
antibody
Prior art date
Application number
YU2392/80A
Other languages
English (en)
Other versions
YU239280A (en
Inventor
P C S Kung
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26758322&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU44411(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Priority to SI8012392A priority Critical patent/SI8012392A8/sl
Publication of YU239280A publication Critical patent/YU239280A/xx
Publication of YU44411B publication Critical patent/YU44411B/xx
Priority to HRP-2392/80A priority patent/HRP940786B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
YU2392/80A 1979-09-18 1980-09-18 Process for obtaining a monoclonal antibody YU44411B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI8012392A SI8012392A8 (sl) 1979-09-18 1980-09-18 Postopek za pridobivanje monoklonalnega protitelesa
HRP-2392/80A HRP940786B1 (en) 1979-09-18 1994-10-26 Hybrid cell line for production of monoclonal antibody for human cytotoxic and supressor t cells, antibody and process

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7664279A 1979-09-18 1979-09-18
US06/082,515 US4364932A (en) 1979-09-18 1979-10-09 Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same

Publications (2)

Publication Number Publication Date
YU239280A YU239280A (en) 1984-04-30
YU44411B true YU44411B (en) 1990-08-31

Family

ID=26758322

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2392/80A YU44411B (en) 1979-09-18 1980-09-18 Process for obtaining a monoclonal antibody

Country Status (19)

Country Link
US (1) US4364932A (da)
EP (1) EP0025722B2 (da)
AU (1) AU537806B2 (da)
CA (1) CA1170593A (da)
DE (2) DE3070669D1 (da)
DK (1) DK154566C (da)
ES (1) ES8200559A1 (da)
FI (1) FI75364C (da)
GR (1) GR70286B (da)
HK (1) HK23986A (da)
IE (1) IE50534B1 (da)
IL (1) IL61063A (da)
MY (1) MY8600515A (da)
NO (1) NO159884C (da)
NZ (1) NZ194982A (da)
PH (1) PH16567A (da)
PT (1) PT71814B (da)
SG (1) SG6386G (da)
YU (1) YU44411B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803262A (en) * 1979-10-09 1989-02-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
US4637983A (en) * 1979-10-09 1987-01-20 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4524025A (en) * 1982-06-30 1985-06-18 E. I. Du Pont De Nemours And Company Hybridoma cell lines and monoclonal antibodies to theophylline
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
US5130144B1 (en) * 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4649106A (en) * 1984-06-01 1987-03-10 Dana-Farber Cancer Institute, Inc. Distinguishing subsets of human cells
JPS6179164A (ja) * 1984-09-26 1986-04-22 Amano Pharmaceut Co Ltd 抗原抗体反応の短縮方法
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
WO1987006610A1 (en) * 1986-04-28 1987-11-05 Endotronics, Inc. Method of culturing leukocytes
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5085985A (en) * 1987-11-12 1992-02-04 Becton Dickinson & Co. Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
JP2001523446A (ja) * 1997-11-13 2001-11-27 シェーリング コーポレイション Ｔｈ２細胞枯渇、組成物、方法
WO1999026658A1 (en) 1997-11-24 1999-06-03 Wong Johnson T Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Also Published As

Publication number Publication date
SG6386G (en) 1986-11-21
IE801944L (en) 1981-03-18
IE50534B1 (en) 1986-05-14
DE3070669D1 (en) 1985-06-27
ES495165A0 (es) 1981-11-16
IL61063A (en) 1984-04-30
EP0025722B2 (en) 1999-04-14
DK154566C (da) 1989-04-17
PH16567A (en) 1983-11-18
PT71814A (en) 1980-10-01
EP0025722B1 (en) 1985-05-22
US4364932A (en) 1982-12-21
DE25722T1 (de) 1984-07-19
GR70286B (da) 1982-09-03
AU6247680A (en) 1981-04-09
FI75364C (fi) 1988-06-09
PT71814B (en) 1982-03-26
MY8600515A (en) 1986-12-31
NZ194982A (en) 1983-02-15
CA1170593A (en) 1984-07-10
ES8200559A1 (es) 1981-11-16
NO802751L (no) 1981-03-19
NO159884C (no) 1989-02-15
EP0025722A3 (en) 1981-11-04
FI75364B (fi) 1988-02-29
EP0025722A2 (en) 1981-03-25
DK154566B (da) 1988-11-28
FI802917A (fi) 1981-03-19
AU537806B2 (en) 1984-07-12
NO159884B (no) 1988-11-07
IL61063A0 (en) 1980-11-30
YU239280A (en) 1984-04-30
HK23986A (en) 1986-04-11
DK394880A (da) 1981-03-19

Similar Documents

Publication Publication Date Title
YU239280A (en) Process for obtaining a monoclonal antibody
PT70993B (en) A process for making a shampoo
YU11380A (en) Process for obtaining n-benzyl-imidazole
GB2079289B (en) Process for preparing antibody
GB2083836B (en) Monoclonal antibody
YU65680A (en) Process for obtaining 9-amino-alkylfluorene
YU177880A (en) Process for obtaining acyl-carbamides
YU116380A (en) Process for obtaining thiazolylidene-oxo-propionitrile
YU43306B (en) Process for obtaining 2-amino-3-benzoyl-phenylacetamides
ZA806506B (en) A method for production of monoclonal antibodies
YU13180A (en) Process for obtaining spiro-quinolyl-hydantoin
GB8504271D0 (en) Monoclonal antibody
YU108580A (en) Process for obtaining alkoxyalkylidene hydrazinopyridazine
YU44734B (en) Process for obtaining 3-halogen-cephalosporin iminohalogenids
YU259680A (en) Process for obtaining acylcarbamides
YU63980A (en) Process for obtaining n-sulfinyl-carbamates
IL71877A0 (en) Process for obtaining monoclonal antibodies
YU276480A (en) Process for obtaining omega-lactams
YU43221B (en) Process for obtaining imidazobenzodiazepine
GB1551190A (en) Process for making photoconductive materials
YU9680A (en) Process for obtaining a polymerizationcatalyst
YU297780A (en) Process for obtaining glucoso-isomerase
RO76111A2 (ro) Procedeu de obtinere a fenilacetamidei
RO76154A2 (ro) Procedeu de obtinere a 2-metilmercapto-4-clor-5-metoxipirimidinei
RO78711A2 (ro) Procedeu de obtinere a hexacloretanului